GB1567619A - Nchlorrinated organic sulphonic acids and their use as bleaching agents - Google Patents

Nchlorrinated organic sulphonic acids and their use as bleaching agents Download PDF

Info

Publication number
GB1567619A
GB1567619A GB5376476A GB5376476A GB1567619A GB 1567619 A GB1567619 A GB 1567619A GB 5376476 A GB5376476 A GB 5376476A GB 5376476 A GB5376476 A GB 5376476A GB 1567619 A GB1567619 A GB 1567619A
Authority
GB
United Kingdom
Prior art keywords
compound
acid
compounds
sodium
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5376476A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jeyes Group Ltd
Original Assignee
Jeyes Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeyes Group Ltd filed Critical Jeyes Group Ltd
Priority to GB5376476A priority Critical patent/GB1567619A/en
Publication of GB1567619A publication Critical patent/GB1567619A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

(54) N-CHLORINATED ORGANIC SULPHONIC ACIDS AND THEIR USE AS BLEACHING AGENTS (71) We, JEYES GROUP LIMITED, a British Company of Brunel Way, Thetford, Norfolk, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:- This invention is concerned with solid Nchlorinated organic sulphonic acid compounds, the preparation thereof, and compositions containing them. The invention is particularly concerned with solid N-chlorinated organic sulphonic acid compounds suitable for use as germicides, bleaching agents and chlorinating agents, i.e. compounds which may be used as so- called "chlorine release agents" in, for example, detergent and/or disinfectant compositions. A variety of N-chlorinated compounds have been proposed for use as chlorine release agents such as, for example, N,N'-dichlorobenzoylene-urea which is a stable and efficient bleaching agent but which has a very low water solubility.
It has now been found, in accordance with the present invention, that certain Nchlorinated organic sulphonic acid compounds, as hereinafter defined, are generally stable solid compounds having an appreciable water solubility.
Accordingly, the present invention provides, N-chlorinated sulphonic acids of the general formula:
in which R is a group
or
and salts thereof, especially alkali metal salts thereof such as sodium or potassium salts.
Preferred compounds in accordance with the invention are compounds in which R is a group
i.e. 1,3 - dichloro - 1,2,3,4 - tetrahydro 2,4 - dioxoquinazoline - 6 - sulphonic acid derivatives of the formula:
in which M is a sodium or potassium atom.
The new compounds of the invention may be prepared by chlorinating an appropriate sulphonic acid of the formula:
or salt thereof, in which R' represents a group
or -NH-.
Such chlorination is conveniently effected by passing chlorine into a cooled aqueous solution of the appropriate acid in the presence of excess alkali, e.g. sodium hydroxide, sodium carbonate, potassium hydroxide or potassium carbonate.
Alternatively, the chlorination may be effected by passing chlorine into an aqueous solution of the sodium or potassium salt of the sulphonic acid in the presence of excess sodium or potassium acetate or bicarbonate to neutralize the hydrochloric acid formed.
This latter process is preferred for the preparation of compounds wherein R is a group
The starting sulphonic acids of the formula:
may be prepared by sulphonating an appropriate unsubstituted compound of the formula:
with a mixture of sulphuric acid and fuming sulphuric acid. Alternatively the sulphonic acids of formula III may be prepared by wellknown cyclization reactions from substituted benzene sulphonic acids of the formula:
in which R" is an amino or carboxy group (See Japanese Patent No. 26,974; Chem.
Abst. 62, 11833; German Offenlegungsschrift No. 2,131,367; Chem..
Abst. 78,84413). Thus quinzoline - 2,4 diones are generally synthesised by treating anthranilic acids with cyanic acid and cyclising the resulting urea with base, or the anthranilic acids may be fused with urea.
Quinoxaline - 2,3 - diones are synthesised by heating o-phenylenediamines with oxalic acid or alkyl oxalate. Benzimidazolones are formed from o-phenlenediamines by treatment with phosgene or heating with urea.
The active chlorine containing compounds of the invention are stable solids which dissolve in water to release active chlorine and the resulting solutions can be used for bleaching, disinfecting and sterilizing operations. The compounds of the invention may be used per se for addition to water to give such solutions in which case they may be formulated, for example, in tablet form optionally with inert tabletting ingredients.
Alternatively the new compounds may be formulated with other active ingredients such as surface active agents, watersoftening agents, builders such as alkali metal polyphosphates or sequestering agents to give detergent or cleansing compositions also having a bleaching or disinfectant activity.
In order that the invention may be well understood the following Examples are given by way of illustration only.
Example 1 1,2,3,4-Tetrahydro-2,4-dioxo- quinazoline-6-sulphonic acid 2,4(1 H, 3H)-Quinazolinedione (10g) was added portionwise to a stirred mixture of 65% fuming sulphuric acid (10 ml) and concentrated sulphuric acid (40 ml) at room temperature. After the addition was complete the mixture was stirred at 5560 for 30 minutes, cooled, poured onto ice (100 g) and stood in a refrigerator for 1 hour. The colourless crystals were filtered, washed with little ice-cold 6N hydrochloric acid and finally dried in a vacuum oven to give the hydrated title compound, (14.7 g m.p. > 300").
Example 2 1 ,3-Dichloro- 1 ,2,3,4-tetra- hydro-2,4-dioxoquinazoline-6 sulnhonic acid sndium nplt (a) Chlorine was passed rapidly for 5 minutes and slowly for 15 minutes into a vigorously stirred ice-cooled solution of 1,2,3,4 - tetrahydro - 2,4 dioxoquinazoline - 6 - sulphonic acid (10.4 g) and sodium hydroxide (9.6 g) in water (240 ml) at ca. 8". The white precipitate was filtered, washed with a little ice-cold water, then ethyl acetate and dried under vacuum over P2Os (10.1 g).
Active chlorine content 37.8% (theoretical 42.6%).
Recrystallisation from hot water yielded a purer sample as white needles (6.3 g).
Active chlorine content 42.1%.
(b) Chlorine was passed rapidly for 5 minutes and slowly for 15 minutes into a vigorously stirred ice-cooled suspension of 1,2,3,4 - tetrahydro - 2,4 dioxoquianzoline - 6- sulphonic acid, sodium salt [from the acid (10.4 g) and sodium hydroxide] and sodium acetate (10 g) in water (250 ml) at ca. 100. Work-up as in example 2 (a) gave the title compound as a white solid (10.0 g).
Active chlorine content 37.1%.
Example 3 1 ,3-Dichloro- 1,2,3 ,4-tetra- hydro-2,4-dioxoquinazoline-6- sulphonic acid, potassium salt Chlorine was passed rapidly for 5 minutes and slowly for 10 minutes into a vigorously stirred ice-cooled solution of 1,2,3,4tetrahydro - 2,4 - dioxoquinazoline - 6 sulphonic acid (10.4 g) and potassium hydroxide (13.4 g) in water (240 ml) at ca.
60. The white precipitate was filtered, washed with a little ice-cold water, then ethyl acetate and vacuum dried over P205 at ca. 400 (13.2 g).
Active chlorine content 36.5% (theoretical 40.6%) Recrystallisation from hot water yielded colourless needles (8.85 g).
Active chlorine content 39.6%.
Example 4 1,2,3,4-Tetrahydro-2,3-dioxo quinoxaline-6-sulphonic acid 2,3(1H,4H)-Quinoxalinedione (10 g) was added portionwise to a stirred mixture of 65 /" fuming sulphuric acid (10 ml) and conc.
sulphuric acid (40 ml) at room temperature.
After stirring for 30 minutes at 5560 the mixture was worked up as in Exampe I to give the hydrated crystalline product (15.3 g, mp. > 3000).
Example 5 1 ,4-Dichloro- 1 ,2,3,4-tetra- hydro-2,3-dioxoquinoxaline-6 sulphonic acid, sodium salt.
Chlorine was passed rapidly for 5 minutes and slowly for 15 minutes into a vigorously stirred ice-cooled suspension of 1,2,3,4 - tetrahydro - 2,3 - dioxoquinoxaline - 6sulphonic acid sodium salt [from the acid (2.6 g) neutralised with sodium hydroxide] and sodium acetate (4 g) in water (60 ml) at ca. 80. The yellowish precipitate was filtered, washed with ice-cold water and ethyl acetate, and vacuum dried to give a slighly yellowish solid (2.80 g).
Active chlorine content 38.3% (theoretical 42.6%).
Recrystallisation from hot water gave a sample as almost white needles.
Active chlorine content 41.8%.
Example 6 1,4-Dichloro-1,2,3,4-tetra- hydro-2,3-dioxoquinoxaline-6 sulphonic acid, potassium salt Chlorine was passed rapidly for 3 minutes and slowly for 15 minutes into a stirred suspension of 1,2,3,4 - tetrahydro - 2,3 dioxoquinoxaline - 6- sulphonic acid potassium salt [from the acid (2.6 g) neutralised with potassium hydroxide] and potassium acetate (4 g) in water (60 ml) at ca. 8". Work-up as in Example 5 gave the product as a slightly yellowish solid (2.48 g).
Active chlorine content 36.7% (theoretical 40.6%) Example 7 2,3-Dihydro( 1 H)-2-oxo- benzimidazole-5-sulphonic acid 2(3H)-benzimidazolone (10 g) was added portionwise to a stirred mixture of 65% fuming sulphuric acid (10 ml) and conc.
sulphuric acid (40 ml) at room temperature, and the mixture then stirred for 30 minutes at 5560 . Work-up as in Example 1 gave the title compound as colourless crystals (14.7 g, m.p. > 3000).
Example 8 1 ,3-Dichloro-2,3-dihydro( 1 H)-2 oxobenzimidazole-5-sulphonic acid, sodium salt.
Chlorine was passed rapidly for 5 minutes and slowly for 10 minutes into a vigorously stirred ice-cooled suspension of 2,3 dihydro - (lH) - 2 - oxobenzimidazole 5 - sulphonic acid sodium salt - from the acid (4.28 g) neutralised with sodium hydroxides and sodium acetate (8.0 g) in water (100 ml) at ca. 60. Work-up as in Example 5 gave a white solid (4.2 g).
Active chlorine content 42.1% (theoretical 46.2 n) Example 9 1,2,3,4-Tetrahydro-2,4-dioxo- quinazoline-7-sulphonic acid sodium salt A solution of potassium cyanate (5.5 g) in water (25 ml) was added dropwise to a stirred solution of 3 - amino - 4carboxybenzenesulphonic acid (10.85 g) [for preparation see Chem. Abstr. 56, 7195] in water (250 ml), adjusted to ca. pH 5 with sodium hydroxide solution, and glacial acetic acid (5 ml). After stirring for 1 hour at room temperature a saturated aqueous solution of sodium hydroxide (60 g) was added with cooling, and the mixture stirred for a further 30 minutes. The mixture was cooled in an ice bath and acidified with 18 N sulphuric acid (90 ml). The precipitate was filtered and recrystallised from water (ca.
200 ml), to yield the title compound as white crystals (9.5 g), m.p. > 350 Example 10 1 ,3-Dichloro- 1 2,3,4-tetrahydro- 2,4-dioxoquinazoline-7-sulphonic acid, sodium salt.
Chlorine was passed rapidly for five minutes and slowly for twenty minutes into a rapidly stirred suspension of 1,2,3,4 - tetrahydro - 2,4 - dioxoquinazoline - 7sulphonic acid, sodium salt (2.64 g) and sodium acetate (4 g) in water (50 ml) at ca.
8". The yellowish precipitate was filtered, washed with ice-cold water, then ethyl acetate and vacuum dried over P2Os to give the title compound (2.25 g) as a white solid.
Active chlorine content 39.75 (theoretical 42.6in).
WHAT WE CLAIM IS: 1. N-chlorinated sulphonic acids of the general formula:
in which R is a group
or
and salts thereof.
2. Compounds as claimed in Claim I of the formula:
in which M is a sodium or potassium atom.
3. Compounds as claimed in Claim I as specifically disclosed in the Examples herein.
4. A process for the preparation of a compound as claimed in Claim 1 which comprises chlorinating a compound of the formula:
in which R' is a group
5. A process as claimed in Claim 4, substantially as hereinbefore described with reference to the Examples.
6. A tablet comprising a compound as claimed in any one of Claims 1-3 together with inert tabletting ingredients.
7. A detergent or cleansing composition comprising a compound as claimed in any one of Claims 1-3 together with a surface active agent.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (7)

**WARNING** start of CLMS field may overlap end of DESC **. acetate and vacuum dried over P2Os to give the title compound (2.25 g) as a white solid. Active chlorine content 39.75 (theoretical 42.6in). WHAT WE CLAIM IS:
1. N-chlorinated sulphonic acids of the general formula:
in which R is a group
or
and salts thereof.
2. Compounds as claimed in Claim I of the formula:
in which M is a sodium or potassium atom.
3. Compounds as claimed in Claim I as specifically disclosed in the Examples herein.
4. A process for the preparation of a compound as claimed in Claim 1 which comprises chlorinating a compound of the formula:
in which R' is a group
5. A process as claimed in Claim 4, substantially as hereinbefore described with reference to the Examples.
6. A tablet comprising a compound as claimed in any one of Claims 1-3 together with inert tabletting ingredients.
7. A detergent or cleansing composition comprising a compound as claimed in any one of Claims 1-3 together with a surface active agent.
GB5376476A 1976-12-23 1976-12-23 Nchlorrinated organic sulphonic acids and their use as bleaching agents Expired GB1567619A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5376476A GB1567619A (en) 1976-12-23 1976-12-23 Nchlorrinated organic sulphonic acids and their use as bleaching agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5376476A GB1567619A (en) 1976-12-23 1976-12-23 Nchlorrinated organic sulphonic acids and their use as bleaching agents

Publications (1)

Publication Number Publication Date
GB1567619A true GB1567619A (en) 1980-05-21

Family

ID=10468904

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5376476A Expired GB1567619A (en) 1976-12-23 1976-12-23 Nchlorrinated organic sulphonic acids and their use as bleaching agents

Country Status (1)

Country Link
GB (1) GB1567619A (en)

Similar Documents

Publication Publication Date Title
EP0206435B1 (en) 2,4-dihalo-5-substituted phenylhydrazines and their production and use
JPS6317832B2 (en)
IL27126A (en) 1,2,3,4-tetrahydro-6-sulfamyl-4-(3h)quinazolinones and process for preparing the same
EP0000200B1 (en) New n-amidino-3,5-diamino-6-substituted-2-pyrazinecarboxamides and process for preparing same
US3882138A (en) Oxazole and oxadiazole benzoic acid derivatives as herbicides
EP0068407A1 (en) Aminosulfonylbenzoic acid derivatives
DK146444B (en) METHOD OF ANALOGY FOR THE PREPARATION OF 1-OXO-2,3-HYDROCARBYLEN-5-INDANYLOXY-ACETIC ACIDS OR SALTS THEREOF WITH BASES
US4267325A (en) Bleaching agents
HU196188B (en) Process for preparing new quinazolindione-derivatives and medical compounds containing them
US3692795A (en) 3-amino-isothiazoles, derivatives thereof and processes for the production thereof
GB1567619A (en) Nchlorrinated organic sulphonic acids and their use as bleaching agents
IL116384A (en) Ylidene compounds and their preparation
JPH0513151B2 (en)
US4151210A (en) Process for the production of phenylalkyl sulphones
US3988347A (en) Process for the preparation of substituted indazoles
US3562272A (en) Preparation of 4-aryl-2(1h)-quinazolinones
SU534182A3 (en) Method for preparing sulfur-containing trialkoxybenzoylaminocarboxylic acid derivatives or their salts
JPS5910747B2 (en) Process for producing 3,3-bis-(4-dimethylaminophenyl)-6-dimethylaminophthalide
US4069228A (en) Coumarins containing sulphonylamino groups
US3201475A (en) Bisglyoxalyldiphenyl derivatives
US3652565A (en) Novel dibasic acid compounds and means for the production thereof
SU431166A1 (en) METHOD OF OBTAINING SULPHONES OR SULPHONAMIDES OF AMINOBENZ-2,1,3-TIADIAZOLE
JPH04273855A (en) Preparation of ureidoperoxycarboxylic acid
KR100235373B1 (en) Process for the preparation of a dextrogyral isomer of an isoindolinone derivative
US4548761A (en) Process for the preparation of 1-aminobenzene-2-sulphonic acids

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940323